Season 2 (2021-2030)

Respiratory - Peptide (1)

Modality Indication Targets Stage Company Project No. Detail
1 Derivation of lead candidates for idiopathic 
pulmonary fibrosis treatment through inhalant 
optimization of integrin selective binding peptide
Peptide IPF Integrin αVβ-3,5,6 Lead NEXEL HN22C0012
BACK